BIT/1REGN (BIT/1REGN)

Borsa Italiana: BIT/1REGN · EUR

€650

-2.50 (-0.4%)· Recorded snapshot

Market cap	73.1B
Revenue (ttm)	13.6B
Net income (ttm)	3.8B
EPS (ttm)	€36.3
P/E (trailing)	17.9x
P/E (forward)	11.5x
Dividend	€3.18 (0.49%)
Volume	1

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.6B
Net income (ttm): 3.8B
EPS (ttm): €36.3
P/E (trailing): 17.9x
P/E (forward): 11.5x
Market cap: 73.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E17.9

P25 n/aP50 n/aP75 n/a

ROE14

P25 n/aP50 n/aP75 n/a

ROIC13.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BIT/1REGN indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-10-30
Employees	15,410
Employees change	185
Employees growth	1.22%
Enterprise value	EUR 59.6B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1988
Industry	Biotechnology
Is primary listing	No
ISIN number	US75886F1075
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	EUR 73.1B
Next earnings date	2026-10-30
Price	EUR 649.80
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-02
Symbol	bit/1REGN
Website	https://www.regeneron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.32x
Average P/E ratio (3Y)	19.22x
Average P/E ratio (5Y)	16.94x
Earnings yield	5.58%
EV/Earnings	15.72x
EV/EBIT	15.9x
EV/EBITDA	14.01x
EV/FCF	18.1x
EV/Sales	4.27x
FCF / EV yield	5.53%
FCF yield	4.5%
Forward P/E	11.52x
Graham number	432.18207
Graham upside	-33.49%
Lynch fair value	EUR 168.31
Lynch upside	-74.1%
P/(FCF - SBC) ratio	30.13x
P/(OCF - SBC) ratio	22.62x
P/B ratio	2.63x
P/E ratio	17.92x
P/FCF ratio	22.22x
P/OCF ratio	17.85x
P/S ratio	5.38x
Price / tangible book value	2.75x
Price/EBITDA ratio	17.77x
Sector forward P/E	16.78x
Sector P/E	20.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.87%
EBITDA margin	30.27%
Effective tax rate	16.21%
FCF margin	23.63%
Gross margin	44.46%
Operating margin	26.87%
Pretax margin	33.25%
Profit margin	27.86%
Profit per employee	EUR 245,874
Profitable quarters	58
Profitable years	14
Revenue per employee	EUR 882,383
ROA	6.53%
ROA (5Y)	11.91%
ROCE	11.53%
ROE	14.04%
ROE (5Y)	24.44%
ROIC	13.5%
ROIC (5Y)	28.16%
SBC / revenue	6.35%
Tax / revenue	5.39%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	1.92%
EPS growth (Q)	-4.53%
EPS growth (QoQ)	81.19%
EPS growth 10Y	20.22%
EPS growth 3Y	2.25%
EPS growth 5Y	-6.1%
EPS growth years	2
FCF growth	-2.42%
FCF growth (Q)	-38.1%
FCF growth (QoQ)	-32.48%
FCF growth 3Y	-3.26%
FCF growth 5Y	17.3%
Gross profit growth	2.61%
Gross profit growth (Q)	20.82%
Gross profit growth 3Y	0.47%
Gross profit growth 5Y	-2.58%
Net income growth	-2.91%
Net income growth (Q)	-6.81%
Net income growth (QoQ)	78.34%
Net income growth 3Y	0.23%
Net income growth 5Y	-6.95%
Net income growth years	2
OCF growth	-1.31%
OCF growth (Q)	-28.96%
OCF growth (QoQ)	-24.65%
OCF growth 10Y	11.2%
OCF growth 3Y	-0.41%
OCF growth 5Y	15.56%
Operating income growth	5.49%
Operating income growth (Q)	30.38%
Operating income growth 3Y	-1.89%
Operating income growth 5Y	-8.98%
Revenue growth	9.29%
Revenue growth (Q)	16.74%
Revenue growth (QoQ)	19.01%
Revenue growth 10Y	12.82%
Revenue growth 3Y	7.03%
Revenue growth 5Y	4.64%
Revenue growth quarters	5
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -806.1M
Depreciation and amortization	EUR 474M
EBIT	EUR 3.7B
EBITDA	EUR 4.1B
EPS	EUR 36.26
Financing cash flow	EUR -3.1B
Free cash flow	EUR 3.3B
Free cash flow minus SBC	EUR 2.4B
Gross profit	EUR 6B
Income taxes	EUR 732.9M
Investing cash flow	EUR -616.4M
Net cash flow	EUR 394.2M
Net income	EUR 3.8B
Operating cash flow minus SBC	EUR 3.2B
Operating income	EUR 3.7B
Revenue	EUR 13.6B
Stock-based compensation	EUR 863.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.47
Book value per share	EUR 276.69
Debt / EBITDA	0.57
Debt / equity	0.09
Debt / FCF	0.72
Interest coverage	75.34
Long-term assets	EUR 20B
Long-term liabilities	EUR 3.8B
Net cash (debt)	EUR 13.2B
Net cash / market cap	18.09%
Net cash growth	1.98%
Net debt / EBITDA	-3.21
Net debt / equity	-0.48
Net debt / FCF	-4.02
Piotroski F-Score	5
Property, plant and equipment	EUR 4.9B
Shareholders' equity	EUR 27.8B
Tangible book value	EUR 26.6B
Tangible book value per share	EUR 265.26
Total assets	EUR 36.5B
Total cash	EUR 7B
Total debt	EUR 2.4B
Total liabilities	EUR 8.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	EUR 16.5B
Current liabilities	EUR 5B
Current ratio	3.34
Inventory turnover	2.74
Net working capital	EUR 4.9B
Quick ratio	2.63
Working capital	EUR 11.3B
Working capital turnover	1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.76%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-31
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	EUR 3.18
Dividend yield	0.49%
Ex-dividend date	2026-08-17
Last dividend	EUR 0.81
Payout ratio	8.74%
Shareholder yield	5.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 624.41
1D price change	-0.38%
1M price change	-7.5%
1M total return	-7.5%
1W price change	-7.07%
1W total return	-7.07%
1Y price change	24.44%
1Y return CAGR	25.09%
1Y total return	25.07%
20-day SMA	EUR 681.91
200-day SMA	EUR 631.95
3M price change	17.61%
3M total return	17.75%
3Y price change	-16.85%
3Y return CAGR	-5.67%
3Y total return	-16.06%
50-day SMA	EUR 682.06
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 724.70
52-week high date	2026-09-03
52-week low	EUR 467.50
52-week low date	2025-10-13
5Y price change	31.14%
5Y return CAGR	5.77%
5Y total return	32.39%
6M price change	-2.75%
6M total return	-2.49%
All-time high	EUR 1,082.00
All-time high date	2024-08-27
All-time low	EUR 303.35
All-time low date	2020-01-30
Average true range (ATR)	EUR 7.83
Average volume	3.1
Change from 52-week high	-10.34%
Change from 52-week low	39%
Change from all-time high	-39.94%
Change from all-time low	114.21%
Change from open	-1.52%
Day's gap	1.15%
Dollar volume	EUR 650
High price	EUR 659.80
Low price	EUR 659.80
Monthly RSI	50.85
Open price	EUR 659.80
Previous close	EUR 652.30
Price vs 150-day SMA	4.07%
Price vs 20-day SMA	-4.71%
Price vs 200-day SMA	2.82%
Price vs 50-day SMA	-4.73%
Relative volume	0.33
RSI	37.05
Sharpe ratio	0.77
Sharpe ratio (3Y)	-0.16
Sharpe ratio (5Y)	0.24
Sortino ratio	1.34
Sortino ratio (3Y)	-0.05
Sortino ratio (5Y)	0.53
Volume	1
Weekly RSI	51.85
YTD price change	-1.19%
YTD total return	-0.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	95.8M
Shares change (QoQ)	-1.58%
Shares change (YoY)	-4.76%
Shares held by insiders	3.83%
Shares held by institutions	93.74%
Short ratio	2.9 days

Deeper analysis on BIT/1REGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1REGN report

Is a complete BIT/1REGN research report available?

No complete published report is available for bit/1REGN (BIT/1REGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1REGN (BIT/1REGN)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1REGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1REGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1REGN

Frequently asked questions